Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Forma Therapeutics Holdings, Inc. | fmtx-ex312_7.htm |
| EX-31.1 - EX-31.1 - Forma Therapeutics Holdings, Inc. | fmtx-ex311_6.htm |
| 10-Q - 10-Q - Forma Therapeutics Holdings, Inc. | fmtx-10q_20210630.htm |
Exhibit 32.1
CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Forma Therapeutics Holdings, Inc. (the “Company”) for the quarter ended June 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, that, to the best of their knowledge:
|
|
(1) |
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
|
|
(2) |
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
/s/ Frank D. Lee |
|
Frank D. Lee |
|
President and Chief Executive Officer |
|
(Principal Executive Officer) |
Dated: August 13, 2021
|
/s/ Todd Shegog |
|
Todd Shegog |
|
Chief Financial Officer |
|
(Principal Financial and Accounting Officer) |
Dated: August 13, 2021